Laurel Wealth Advisors (California)’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-25,243
| Closed | -$230K | – | 722 |
|
|
2022
Q1 | $230K | Hold |
25,243
| – | – | 0.02% | 671 |
|
|
2021
Q4 | $516K | Sell |
25,243
-60
| -0.2% | -$1.23K | 0.04% | 442 |
|
|
2021
Q3 | $646K | Hold |
25,303
| – | – | 0.12% | 201 |
|
|
2021
Q2 | $885K | Buy |
25,303
+176
| +0.7% | +$6.16K | 0.11% | 190 |
|
|
2021
Q1 | $837K | Buy |
25,127
+127
| +0.5% | +$4.23K | 0.13% | 177 |
|
|
2020
Q4 | $649K | Sell |
25,000
-200
| -0.8% | -$5.19K | 0.1% | 202 |
|
|
2020
Q3 | $249K | Buy |
+25,200
| New | +$249K | 0.04% | 336 |
|
|
2019
Q2 | – | Sell |
-26,000
| Closed | -$188K | – | 411 |
|
|
2019
Q1 | $188K | Buy |
+26,000
| New | +$188K | 0.05% | 363 |
|